Gleason score 7 prostate cancer treated with interstitial brachytherapy with or without supplemental external beam radiation and androgen deprivation therapy: Is the primary pattern on needle biopsy prognostic?-Reference-Cited by-同舟云学术

Gleason score 7 prostate cancer treated with interstitial brachytherapy with or without supplemental external beam radiation and androgen deprivation therapy: Is the primary pattern on needle biopsy prognostic?

Published:2013-01 Issue:1 Volume:12 Page:14-18
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Bittner Nathan,Merrick Gregory S.,Butler Wayne M.,Galbreath Robert W.,Adamovich Edward,Wallner Kent E.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference18 articles.

1. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy;Lerner;J Urol,1996

2. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results;Roehl;Urology,2004

3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer;D’Amico;J Am Med Assoc,1998

4. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Available at: http://www.nccn.org/professionals/physician_gls/about.asp. Accessed November 14, 2011.

5. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium;Partin;Urology,2001

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Radiation Therapy versus Brachytherapy: Relative Strengths of Two Highly Efficient Options for the Treatment of Localized Prostate Cancer;Cancers;2022-04-29

2. Effect of adding androgen deprivation therapy to permanent iodine-125 implantation with or without external beam radiation therapy on the outcomes in patients with intermediate-risk prostate cancer: A propensity score–matched analysis;Brachytherapy;2021-01

3. Transperineal mapping biopsy improves selection of brachytherapy boost for men with localized prostate cancer;Brachytherapy;2020-01

4. Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer;Translational Andrology and Urology;2018-09

5. Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2–3) and Implications for Risk Stratification: A Systematic Review;European Urology Focus;2017-10